MILabs » Archive by category 'News'

Interview with MILabs founder at World Physics News

Video report: MILabs founder Freek Beekman describes how high-resolution SPECT systems play an invaluable role in small-animal imaging, e.g. for development of new therapeutic strategies for human medicine, offering, for example, a means to accurately track (the response of) pharmaceuticals in animal models of cancer, diabetes and other diseases. Imaging tiny animals such as mice necessitates extremely [...]

MILabs U-SPECT/CT in operation at Moscow State University

MILabs is excited to announce the recent delivery of a U-SPECT-II/CT to Moscow State University, in Moscow, Russia.  The U-SPECT-II/CT is the very first pre-clinical system to be used for in vivo radio-molecular imaging research in the Russian Federation.  Professor Alexander Sobolev and his research team will utilize the system to answer issues relating to [...]

Mayo Clinic orders MILabs SPECT/CT to expand their molecular imaging capabilities

Mayo Clinic, in Rochester, MN  recently ordered a MILabs U-SPECT-II/CT to enhance and expand their current small animal molecular imaging capabilities. The Mayo Clinic has utilized both microSPECT and microPET in their molecular imaging research programs for several years.  They selected the U-SPECT-II/CT system to update their SPECT imaging technologies because of the ultra-high resolution [...]

University of British Columbia, in Vancouver, BC selected MILabs’ VECTor/CT to further its brain research programs

The University of British Columbia, in Vancouver, BC has selected the MILabs VECTor/CT system to further its brain research programs and to also perform important new work in oncology.  The VECTor/CT will be placed in the new UBC Centre of Comparative Medicine Facility. The CCM facility is located next to TRIUMF, Canada’s national laboratory for [...]

Installation of MILabs U-SPECT-II/CT at the Center for In Vivo Microscopy, Duke University

At Duke University, Durham, NC, the Center for In Vivo Microscopy (CIVM) has recently ordered a MILabs U-SPECT-II/CT system to enhance their comprehensive program dedicated to developing novel methods for preclinical imaging, focusing on the highest possible spatial resolution and applying those methods to important biomedical problems. The CIVM is a NIH/NCRR-funded National Biomedical Technology [...]

Next Page »